Skip to main content

E-learning | Early intervention in Multiple Sclerosis: the role of high-efficacy therapies in long-term outcomes (certified by Paradigms)

E-learning | Early intervention in Multiple Sclerosis: the role of high-efficacy therapies in long-term outcomes (certified by Paradigms)

Explore the role of early high-efficacy therapies in Multiple Sclerosis through expert-led presentations covering treatment strategies, clinical evidence, biomarkers, and long-term patient outcomes.

Treatment decisions made early in Multiple Sclerosis (MS) may have important implications for long-term neurological outcomes. But how does early high-efficacy treatment compare with traditional escalation strategies?

This e-learning examines evidence from clinical trials, international registries and emerging biomarker research. Explore how treatment timing, disease activity and individual risk profiles can inform therapeutic decisions aimed at preserving long-term brain health.

Access the e-learning

What does this e-learning include?

This 1-hour, self-paced course includes:

  • Expert presentations on early high-efficacy treatment versus traditional escalation strategies.
  • Clinical evidence on disability progression, biomarkers and long-term brain health.
  • A satisfaction survey and a final assessment to consolidate learning.
  • A ParadigMS Foundation Certificate of Participation upon successful completion.

Media

Details

  • Directors

    ParadigMS Foundation

  • Author(s)

    Tjalf Ziemssen and Bart Van Wijmeersch

  • Country

    Germany and Belgium

  • Release Date

    October 30, 2026

  • Views

    Views: 23

We value your opinion.

Selected Value: 1
Give a score from 1 (= not at all likely) to 10 (extremely likely)
Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.
If you have submitted a question above, leave your email so we can get back to you.

You Might Also Like

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.